Prevalence, Risk Factors and Genetic Characterisation of Extended-spectrum Beta-lactamase and Carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a Community-based Cross-sectional Study, the Netherlands, 2014 to 2016
Overview
Authors
Affiliations
BackgroundThe epidemiology of carriage of extended-spectrum beta-lactamase-producing (ESBL-E) and carbapenemase-producing Enterobacteriaceae (CPE) in the general population is unknown.AimIn this observational study, the prevalence and risk factors for intestinal ESBL-E and CPE carriage in the Dutch general population were determined. ESBL-E were characterised.MethodsFrom 2014 to 2016, ca 2,000 residents were invited monthly to complete a questionnaire and provide a faecal sample, which was tested for ESBL-E. The first 1,758 samples were also tested for CPE. Risk factors for ESBL-E carriage were identified by multivariable logistic regression analysis. ESBL-E isolates underwent whole genome sequencing.ResultsOf 47,957 individuals invited, 4,177 (8.7%) completed the questionnaire and provided a faecal sample. ESBL-E were detected in 186 (4.5%) individuals, resulting in an adjusted prevalence of 5.0% (95% confidence interval (CI):3.4-6.6%). Risk factors were: born outside the Netherlands (odds ratio (OR): 1.99; 95% CI: 1.16-4.54), eating in restaurants > 20 times/year (OR: 1.70; 95% CI: 1.04-2.76), antibiotic use < 6 months ago (OR: 2.05; 95% CI: 1.05-4.03), swimming in sea/ocean < 12 months ago (OR: 1.63; 95% CI: 1.11-2.39), travelling to Africa (OR: 3.03; 95% CI: 1.23-7.46) or Asia (OR: 2.00; 95% CI: 1.02-3.90) < 12 months ago, and not changing kitchen towels daily (OR: 2.19; 95% CI: 1.24-3.87). The last had the largest population attributable risk (PAR) (47.5%). Eighty-four of 189 (44.4%) ESBL-E isolates carried . isolates belonged to 70 different sequence types (ST)s, of which ST131 (42/178 isolates; 23.6%) was most prevalent. Associations were observed between IncFIA plasmids and ST131 and , and between IncI1 and ST88 and . No CPE were detected.ConclusionsThe prevalence of ESBL-E carriage in the Netherlands' community-dwelling population is 5.0%. Identified risk factors were mostly travelling (particularly to Asia and Africa) and kitchen hygiene. CPE were not detected.
Caddey B, Fisher S, Barkema H, Nobrega D Clin Microbiol Rev. 2025; 38(1):e0014622.
PMID: 39853095 PMC: 11905369. DOI: 10.1128/cmr.00146-22.
Gray H, Biggs P, Midwinter A, Rogers L, Fayaz A, Akhter R Microb Genom. 2025; 11(1.
PMID: 39791259 PMC: 11718517. DOI: 10.1099/mgen.0.001341.
Houkes K, Weterings V, van den Bijllaardt W, Tinga M, Mulder P, Kluytmans J Antimicrob Resist Infect Control. 2024; 13(1):102.
PMID: 39267161 PMC: 11396308. DOI: 10.1186/s13756-024-01460-y.
Ishnaiwer M, Le Bastard Q, Naour M, Zeman M, Dailly E, Montassier E Gut Microbes. 2024; 16(1):2347021.
PMID: 38685762 PMC: 11062366. DOI: 10.1080/19490976.2024.2347021.
Dequeker S, van Hensbergen M, den Heijer C, Dhaeze W, Raven S, Ewalts-Hakkoer H BMC Infect Dis. 2024; 24(1):131.
PMID: 38267878 PMC: 10809597. DOI: 10.1186/s12879-024-08996-9.